SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
InVivo Therapeutics Corporation Expects to Commence Human Study after Meeting on IDE Filing for Biopolymer Scaffolding to Treat Spinal Cord Injuries